Hangzhou Coco Healthcare Products Co.,Ltd. (SHE:301009)
8.47
-0.39 (-4.40%)
Sep 15, 2026, 3:00 PM CST
SHE:301009 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 671.03 | 811.16 | 613.7 | 863.06 | 689.46 | 884.04 |
Trading Asset Securities | 310.94 | 190.92 | 250.05 | - | - | - |
Cash & Short-Term Investments | 981.97 | 1,002 | 863.75 | 863.06 | 689.46 | 884.04 |
Cash Growth | 7.05% | 16.02% | 0.08% | 25.18% | -22.01% | 92.50% |
Accounts Receivable | 218.08 | 222.37 | 226.15 | 196.3 | 264.29 | 176.93 |
Other Receivables | 3.39 | 4.38 | 4.31 | 5.16 | 5.32 | 4.91 |
Receivables | 221.47 | 226.75 | 230.47 | 201.46 | 269.61 | 181.84 |
Inventory | 142.49 | 141.16 | 141.88 | 114.82 | 182.42 | 153.95 |
Prepaid Expenses | - | - | - | - | - | 1.95 |
Other Current Assets | 46.49 | 31.36 | 39.56 | 25.39 | 17.04 | 32.01 |
Total Current Assets | 1,392 | 1,401 | 1,276 | 1,205 | 1,159 | 1,254 |
Property, Plant & Equipment | 622.01 | 639.83 | 686.73 | 663.37 | 670.41 | 694.84 |
Long-Term Investments | 22.64 | 11.1 | 16.87 | 9.7 | 0.25 | 0.25 |
Other Intangible Assets | 92.07 | 90.69 | 81.68 | 82.51 | 84.86 | 86.99 |
Long-Term Deferred Tax Assets | 15.77 | 11.96 | 11.36 | 10.06 | 8.19 | 2.07 |
Long-Term Deferred Charges | 13.64 | 15.53 | 17.1 | 20.44 | 21.21 | 23.45 |
Other Long-Term Assets | 34.29 | 7.25 | 0.16 | 1.21 | 5.19 | 24.24 |
Total Assets | 2,193 | 2,178 | 2,090 | 1,992 | 1,949 | 2,086 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 465.97 | 465.1 | 480.96 | 439.02 | 429.92 | 528.46 |
Accrued Expenses | 18.26 | 33.99 | 33.94 | 28.85 | 28.82 | 27.79 |
Short-Term Debt | 258.9 | 200.14 | 100.13 | 2.78 | - | - |
Current Portion of Long-Term Debt | 4.04 | - | - | - | - | - |
Current Portion of Leases | - | 3.95 | 3.7 | 3.39 | 1.35 | 1.54 |
Current Income Taxes Payable | 6.13 | 0.03 | 0.01 | 1.26 | 3.5 | 0 |
Current Unearned Revenue | 4.73 | 4.61 | 5.9 | 6.01 | 7.05 | 5.99 |
Other Current Liabilities | 9.21 | 3.14 | 3.03 | 4 | 3.9 | 2.9 |
Total Current Liabilities | 767.23 | 710.96 | 627.67 | 485.3 | 474.54 | 566.67 |
Long-Term Leases | 5.01 | 4.98 | 8.18 | 11.88 | 3.29 | 5.07 |
Long-Term Unearned Revenue | 37.78 | 40.44 | 42.2 | 45.22 | 39.05 | 6.84 |
Total Liabilities | 810.02 | 756.38 | 678.06 | 542.4 | 516.88 | 578.59 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 271.86 | 271.86 | 271.86 | 271.86 | 271.86 | 271.86 |
Additional Paid-In Capital | 723.24 | 723.24 | 723.24 | 723.24 | 723.24 | 723.24 |
Retained Earnings | 366.22 | 406.1 | 388.68 | 377.64 | 357.46 | 419.62 |
Treasury Stock | -49.69 | -49.69 | -49.69 | - | - | - |
Comprehensive Income & Other | -9.9 | -9.91 | -0.01 | -0.01 | -0 | 0.01 |
Total Common Equity | 1,302 | 1,342 | 1,334 | 1,373 | 1,353 | 1,415 |
Minority Interest | 81.08 | 79.73 | 77.43 | 76.88 | 79.2 | 92.32 |
Shareholders' Equity | 1,383 | 1,421 | 1,412 | 1,450 | 1,432 | 1,507 |
Total Liabilities & Equity | 2,193 | 2,178 | 2,090 | 1,992 | 1,949 | 2,086 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 267.95 | 209.06 | 112.01 | 18.05 | 4.64 | 6.61 |
Net Cash (Debt) | 714.02 | 793.02 | 751.74 | 845.01 | 684.82 | 877.44 |
Net Cash Growth | -5.72% | 5.49% | -11.04% | 23.39% | -21.95% | 143.68% |
Net Cash Per Share | 2.74 | 3.07 | 2.89 | 2.93 | 2.54 | 3.75 |
Filing Date Shares Outstanding | 278.8 | 266.42 | 266.42 | 268.51 | 271.86 | 271.86 |
Total Common Shares Outstanding | 278.8 | 266.42 | 266.42 | 271.86 | 271.86 | 271.86 |
Working Capital | 625.19 | 690.39 | 647.99 | 719.42 | 683.99 | 687.12 |
Book Value Per Share | 4.67 | 5.04 | 5.01 | 5.05 | 4.98 | 5.20 |
Tangible Book Value | 1,210 | 1,251 | 1,252 | 1,290 | 1,268 | 1,328 |
Tangible Book Value Per Share | 4.34 | 4.70 | 4.70 | 4.75 | 4.66 | 4.88 |
Buildings | - | 417.8 | 339.85 | 299.52 | 299.19 | 295.64 |
Machinery | - | 598.22 | 588.05 | 525.39 | 56.77 | 565.38 |
Construction In Progress | - | 7.02 | 83.45 | 107.12 | 93.89 | 31.61 |